Evidence map›Paper›PMID 38879691›Full record

ArticleVirchows Archiv : an international journal of pathology2024

A deep-learning-based model for assessment of autoimmune hepatitis from histology: AI(H).

Caner Ercan, Kattayoun Kordy, Anna Knuuttila, Xiaofei Zhou, Darshan Kumar, Ville Koponen, Peter Mesenbrink, Serenella Eppenberger-Castori, Parisa Amini, Marcos C Pedrosa and 1 more

Abstract read
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. [Pathological characteristics and diagnostic criteria of autoimmune hepatitis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Caner Ercan *Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Schönbeinstrasse 40 4056, Basel, Switzerland. caner.ercan@unibas.ch.ORCID http://orcid.org/0000-0002-5611-2699
Kattayoun Kordy *Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Anna KnuuttilaAiforia Technologies PLC, Helsinki, Finland.
Xiaofei ZhouNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Darshan KumarAiforia Technologies PLC, Helsinki, Finland.
Ville KoponenAiforia Technologies PLC, Helsinki, Finland.
Peter MesenbrinkNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Serenella Eppenberger-CastoriInstitute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Schönbeinstrasse 40 4056, Basel, Switzerland.
Parisa AminiNovartis Institutes for BioMedical Research, Basel, Switzerland.
Marcos C PedrosaNovartis Pharma AG, Basel, Switzerland.
Luigi M TerraccianoDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histological assessment of autoimmune hepatitis (AIH) is challenging. As one of the possible results of these challenges, nonclassical features such as bile-duct injury stays understudied in AIH. We aim to develop a deep learning tool (artificial intelligence for autoimmune hepatitis [AI(H)]) that analyzes the liver biopsies and provides reproducible, quantifiable, and interpretable results directly from routine pathology slides. A total of 123 pre-treatment liver biopsies, whole-slide images with confirmed AIH diagnosis from the archives of the Institute of Pathology at University Hospital Basel, were used to train several convolutional neural network models in the Aiforia artificial intelligence (AI) platform. The performance of AI models was evaluated on independent test set slides against pathologist's manual annotations. The AI models were 99.4%, 88.0%, 83.9%, 81.7%, and 79.2% accurate (ratios of correct predictions) for tissue detection, liver microanatomy, necroinflammation features, bile duct damage detection, and portal inflammation detection, respectively, on hematoxylin and eosin-stained slides. Additionally, the immune cells model could detect and classify different immune cells (lymphocyte, plasma cell, macrophage, eosinophil, and neutrophil) with 72.4% accuracy. On Sirius red-stained slides, the test accuracies were 99.4%, 94.0%, and 87.6% for tissue detection, liver microanatomy, and fibrosis detection, respectively. Additionally, AI(H) showed bile duct injury in 81 AIH cases (68.6%). The AI models were found to be accurate and efficient in predicting various morphological components of AIH biopsies. The computational analysis of biopsy slides provides detailed spatial and density data of immune cells in AIH landscape, which is difficult by manual counting. AI(H) can aid in improving the reproducibility of AIH biopsy assessment and bring new descriptive and quantitative aspects to AIH histology.

Indexed as

Deep LearningHepatitis, AutoimmuneLiverAdultAgedBiopsyFemaleHumansImage Interpretation, Computer-AssistedMaleMiddle AgedNeural Networks, ComputerPredictive Value of TestsReproducibility of ResultsAIHArtificial intelligenceAutoimmune hepatitisComputational pathologyDeep-learning

Identifiers

PMID38879691
PMCPMC11666607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.